Antitumor activity of improsulfan by the fractionated dose schedule on rat ascites tumors.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D008698:Mesylates / Q000627:therapeutic use*; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011437:Propylamines / Q000627:therapeutic use; D051381:Rats; D012517:Sarcoma, Yoshida / Q000188:drug therapy; D013997:Time Factors
D000970:Antineoplastic Agents; D008698:Mesylates; D011437:Propylamines; D003520:Cyclophosphamide